CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Fuan Pharmaceutical Group Co Ltd Company Snapshot
Fuan Pharmaceutical Group Co Ltd operates within the Medicinals and botanicals sector. In addition to historical fundamental analyses, the complete report available to purchase compares Fuan Pharmaceutical Group Co Ltd with three other companies in this sector in CHINA : Tianjin Tianyao Pharmaceutical, Ltd. (2019 sales of 2.92 billion Chinese Renmimbi [US$408.64 million] of which 51% was Preparation), Shandong Jincheng Pharmaceutical Group Co Ltd (2.79 billion Chinese Renmimbi [US$391.69 million] of which 54% was Intermediate), and Hunan ER-KANG Pharmaceutical Co Ltd (2.74 billion Chinese Renmimbi [US$384.62 million] of which 94% was pharmaceutic adjuvant;).

Sales Analysis. During the year ended December of 2019, sales at Fuan Pharmaceutical Group Co Ltd were 2.78 billion Chinese Renmimbi (US$389.72 million). This is an increase of 4.2% versus 2018, when the company's sales were 2.67 billion Chinese Renmimbi. This was the fifth consecutive year of sales increases at Fuan Pharmaceutical Group Co Ltd (and since 2014, sales have increased a total of 520%). Sales of Preparation saw an increase that was more than double the company's growth rate: sales were up 14.7% in 2019, from 1.55 billion Chinese Renmimbi to 1.78 billion Chinese Renmimbi. Fuan Pharmaceutical Group Co Ltd also saw significant increases in sales in Drug Distribution and Other (up 13.7% to 31.10 million Chinese Renmimbi) and Other (up 11.0% to 33.12 million Chinese Renmimbi) . Not all segments of Fuan Pharmaceutical Group Co Ltd experienced an increase in sales in 2019: sales of Apis and Intermediates fell 11.6% to 936.74 million Chinese Renmimbi.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Fuan Pharmaceutical Group Co Ltd
  Stock Performance Chart for Fuan Pharmaceutical Group Co Ltd
 
  Stock Data: Recent Stock Performance:
  Current Price (5/22/2020): 5.01
(Figures in Chinese Renmimbi)
1 Week -6.0%   13 Weeks -16.5%  
4 Weeks -17.6%   52 Weeks -22.8%  
 
Fuan Pharmaceutical Group Co Ltd Key Data:
  Ticker: 300194 Country: China
  Exchanges: SZN Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Medicinals & Botanicals
  2019 Sales 2,780,740,647
(Year Ending Jan 2020).
Employees: 2,986
  Currency: Chinese Renmimbi Market Cap: 5,960,459,034
  Fiscal Yr Ends: December Shares Outstanding: 1,189,712,382
  Share Type: A Gu Closely Held Shares:
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.